3 hrs ago | MediLexicon
Spirit III Results Reaffirm Strong Performance Of Boston Scientific...
Boston Scientific Corporation welcomed two-year results from the SPIRIT III clinical trial, which continue to reaffirm the proven long-term safety and efficacy of the market-leading TAXUS Express2 ...
11 hrs ago | Med Ad News
International Endeavor Registry Reports Safety and Performance of...
“Registries generally enroll more challenging 'real-world' patients than randomized trials”
MINNEAPOLIS & BARCELONA, Spain-- --May 15, 2008 - New data presented today at EuroPCR reports extensive experience on the safety and performance of Medtronic's Endeavor Zotarolimus-Eluting Coronary Stent in ... via Med Ad News
19 hrs ago | Medical News Today
Uroplasty To Highlight Urgent PC System At American Urological Association 2008 Annual Meeting
Main Category: Urology / Nephrology Also Included In: Medical Devices ; Conferences Article Date: 14 May 2008 - 0:00 PDT Uroplasty, Inc. via Medical News Today
Yesterday | The Post Chronicle
Heparin Producer To Raise Prices
APP Pharmaceuticals Inc., Thursday said it was raising the price of its blood thinner heparin in the wake of an ingredient shortage in China. via The Post Chronicle
Thursday | Rehab Management
CardioDynamics Announces Significant ICG Study with Nearly Three...
“These are impressive, real-world results, nearly three times the national average, across a 65-plus multi-specialty physician group practice”
Study results were reported from a 65 physician primary care and cardiology group practice and demonstrated an impressive 102% improvement in blood pressure control rates, with control rates improving from 42% ... via Rehab Management
Thursday | Medical News Today
Endeavor II Four-Year Results Demonstrate Long-Term Safety...
“As the duration of follow-up in ENDEAVOR II grows, so too does our confidence in the enduring safety and effectiveness of the Endeavor stent”
Main Category: Cardiovascular / Cardiology Article Date: 15 May 2008 - 2:00 PDT Today at EuroPCR, Medtronic, Inc. via Medical News Today
Thursday | MediLexicon
Medtronic Announces FDA Approval Of New Vision 3D Wireless Implantable Cardiac Devices
“This also gives us insight into key trend data to help better manage the patient's condition, rather than simply inform us how the implanted device is operating.”
Leading into Heart Rhythm 2008, the pre-eminent worldwide gathering of cardiologists specializing in electrophysiology, Medtronic, Inc. via MediLexicon
Thursday | AMNY
New Heparin Safety Concerns Arise
“I wouldn't be surprised if it has already happened.”
Efforts to make the blood thinner heparin safer -- and to replace supplies that were depleted by a massive recall earlier this year -- have meant unintended and fresh safety concerns for hospitals, heart ... via AMNY
Wednesday | Scientific American
Dennis Quaid backs drugmaker liability suits
“I believe if preemption of lawsuits is allowed to prevail, it will basically make all of us, the public, uninformed and uncompensated lab rats”
Actor Dennis Quaid urged the U.S. Congress on Wednesday to preserve patients' rights to sue drugmakers for injuries, recounting how his newborn twins nearly died from an accidental drug overdose. via Scientific American
Wednesday May 14 | Chicago Tribune
Abbott Laboratories' Xience stent outperforms rival, study says
Abbott Laboratories ' drug-coated Xience heart stent worked almost twice as well as the top-seller, Boston Scientific Corp. via Chicago Tribune







